Skip to content

E4 Pharmaceutical Consulting

E4 Biotechnology and Pharmaceutical Consulting. Providing product development (CMC), regulatory, QA/QC and project management support to companies developing new small-molecule drugs, biologics and medical devices.

Welcome!!

Categories

  • Regulatory (2)
    • Regulatory Strategy (1)
    • Regulatory Submissions (2)

E4 Pharmaceutical Consulting

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS FDA News

RSS Pharma Times

  • MHRA to open new Northern Ireland hub to strengthen UK‑wide life sciences collaboration
    Belfast base will expand regulatory support, boost innovation and deepen engagement
  • Novo Nordisk data shows oral semaglutide delivers significant weight loss in phase 3 trial
    Responders achieved weight loss and improvements in physical function
  • Enterprise reports positive phase 2 data for inhaled ENaC blocker in cystic fibrosis
    Lead candidate ETD001 delivers significant lung function improvement
  • SMC backs first-line metastatic bladder cancer combination after trial results
    Enfortumab vedotin and pembrolizumab recommended for NHS Scotland
  • Poolbeg secures Canadian patent for POLB 001 in cancer immunotherapy‑induced CRS
    Second national grant strengthens company’s expanding global IP estate
  • Pulsesight reports positive phase 1 data for PST‑611 in dry AMD
    Early safety and efficacy signals support move into repeat‑dose phase 2a trial
Proudly powered by WordPress / Theme: Shoreditch by Automattic.